Popular holiday hotspot facing fines after 12-year delay
Cyprus could face hefty fines from the European Union for not shutting down two landfill sites that have been contaminating water and posing a public health risk. The EU pinpointed the dumps at Kotsiatis and Vati as rule-breakers back in 2013, and despite promises to close and rehabilitate the sites, they remain operational.
The EU expressed its concerns, stating: "In 2013, the court ruled that the landfill of Vati in Limassol and the landfill of Kotsiati in Nicosia did not comply with the landfill directive".
On April 28, 2017, Cyprus received a formal notice under Article 260 TFEU, following the court's judgment, according to the statement.
"Although no waste has been sent to these landfills for more than six years, they have still not been rehabilitated and closed as required by the landfill directive," the Commission pointed out.
Moreover, the Commission highlighted that Cyprus has repeatedly delayed the implementation schedule for the judgment, leaving the landfills as ongoing threats to human health and the environment.
The statement concluded with a warning that the case would be referred "back to the Court of Justice of the European Union, requesting the imposition of financial sanctions."
Despite this stern warning from the Commission, Theodoros Mesimeris, head of the Cypriot Environment Department, remains optimistic that Cyprus can dodge the fines.
"For the first time, we have in place a holistic plan for handling all waste streams and for deterring illegal waste-disposal practices," stated Mesimeris.
He announced the strategy will include enhancing the management processes at Kotsiatis and for 71 other landfill sites in Nicosia by 2026. Additionally, Mesimeris noted the Vati site and another 47 sites in Limassol are set for a thorough makeover with completion anticipated by 2029.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Glasgow Times
6 minutes ago
- Glasgow Times
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs cap of 15%
Taoiseach Micheal Martin said the trade agreement represented a 'significant win' for the EU while Tanaiste Simon Harris said it offered an 'important shield' for Irish exporters. The EU struck a trade deal with the US on July 27, five days before Mr Trump said a 30% tariff would kick in for the bloc. The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US. There are 'zero for zero' tariffs on a number of products including aircrafts and aircraft parts, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years. In the aftermath of the deal, it was not clear whether 15% would remain the rate for the pharma sector or be increased. The EU-US statement published on Thursday said that as of September 1, the US will apply a maximum tariff rate of 15% on generic pharmaceuticals, their ingredients and chemical precursors. 'The United States intends to promptly ensure that the tariff rate, comprised of the MFN (Most Favored Nation) tariff and the tariff imposed pursuant to Section 232 of the Trade Expansion Act of 1962, applied to originating goods of the European Union subject to Section 232 actions on pharmaceuticals, semiconductors, and lumber does not exceed 15%.' Mr Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the assurances for the pharmaceutical and semiconductor sectors. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the EU-US agreement would mean in practice. 'This is especially important for enterprises that either import from or export to the US,' he said. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.' Paul Sweetman, chief executive of the American Chamber of Commerce Ireland, welcomed the joint statement as providing 'greater clarity to business on the future of the transatlantic trading partnership, worth over four billion dollars daily'. 'The framework brings more certainty and allows for further work to grow our mutually beneficial economic relationship,' he said. 'In supporting the US-Ireland and US-EU trading relationships into the future, we must also focus on enhancing competitiveness. 'Now is the time to make smart policy and investment decisions to deliver critical infrastructure projects, meet future skills needs, bolster our RD&I ecosystem, and secure Ireland's position as a digital regulatory hub. 'AmCham will continue to work closely with the Irish Government, the US administration and our EU and US partners in growing investment on both sides of the Atlantic.'
Leader Live
an hour ago
- Leader Live
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs cap of 15%
Taoiseach Micheal Martin said the trade agreement represented a 'significant win' for the EU while Tanaiste Simon Harris said it offered an 'important shield' for Irish exporters. The EU struck a trade deal with the US on July 27, five days before Mr Trump said a 30% tariff would kick in for the bloc. The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US. There are 'zero for zero' tariffs on a number of products including aircrafts and aircraft parts, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years. In the aftermath of the deal, it was not clear whether 15% would remain the rate for the pharma sector or be increased. The EU-US statement published on Thursday said that as of September 1, the US will apply a maximum tariff rate of 15% on generic pharmaceuticals, their ingredients and chemical precursors. 'The United States intends to promptly ensure that the tariff rate, comprised of the MFN (Most Favored Nation) tariff and the tariff imposed pursuant to Section 232 of the Trade Expansion Act of 1962, applied to originating goods of the European Union subject to Section 232 actions on pharmaceuticals, semiconductors, and lumber does not exceed 15%.' Mr Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the assurances for the pharmaceutical and semiconductor sectors. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the EU-US agreement would mean in practice. 'This is especially important for enterprises that either import from or export to the US,' he said. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.' Paul Sweetman, chief executive of the American Chamber of Commerce Ireland, welcomed the joint statement as providing 'greater clarity to business on the future of the transatlantic trading partnership, worth over four billion dollars daily'. 'The framework brings more certainty and allows for further work to grow our mutually beneficial economic relationship,' he said. 'In supporting the US-Ireland and US-EU trading relationships into the future, we must also focus on enhancing competitiveness. 'Now is the time to make smart policy and investment decisions to deliver critical infrastructure projects, meet future skills needs, bolster our RD&I ecosystem, and secure Ireland's position as a digital regulatory hub. 'AmCham will continue to work closely with the Irish Government, the US administration and our EU and US partners in growing investment on both sides of the Atlantic.'
Powys County Times
an hour ago
- Powys County Times
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs cap of 15%
Ireland's premier and deputy premier have welcomed clarity on the EU-US trade deal, which sees the US commit to capping tariffs on pharma goods at 15%. Taoiseach Micheal Martin said the trade agreement represented a 'significant win' for the EU while Tanaiste Simon Harris said it offered an 'important shield' for Irish exporters. The EU struck a trade deal with the US on July 27, five days before Mr Trump said a 30% tariff would kick in for the bloc. The deal sees 15% tariffs on most EU goods including cars, semiconductors and pharmaceuticals entering the US. There are 'zero for zero' tariffs on a number of products including aircrafts and aircraft parts, some agricultural goods and certain chemicals – as well as EU purchases of US energy worth 750 billion dollars over three years. In the aftermath of the deal, it was not clear whether 15% would remain the rate for the pharma sector or be increased. The EU-US statement published on Thursday said that as of September 1, the US will apply a maximum tariff rate of 15% on generic pharmaceuticals, their ingredients and chemical precursors. 'The United States intends to promptly ensure that the tariff rate, comprised of the MFN (Most Favored Nation) tariff and the tariff imposed pursuant to Section 232 of the Trade Expansion Act of 1962, applied to originating goods of the European Union subject to Section 232 actions on pharmaceuticals, semiconductors, and lumber does not exceed 15%.' Mr Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the assurances for the pharmaceutical and semiconductor sectors. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the EU-US agreement would mean in practice. 'This is especially important for enterprises that either import from or export to the US,' he said. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.' Paul Sweetman, chief executive of the American Chamber of Commerce Ireland, welcomed the joint statement as providing 'greater clarity to business on the future of the transatlantic trading partnership, worth over four billion dollars daily'. 'The framework brings more certainty and allows for further work to grow our mutually beneficial economic relationship,' he said. 'In supporting the US-Ireland and US-EU trading relationships into the future, we must also focus on enhancing competitiveness. 'Now is the time to make smart policy and investment decisions to deliver critical infrastructure projects, meet future skills needs, bolster our RD&I ecosystem, and secure Ireland's position as a digital regulatory hub. 'AmCham will continue to work closely with the Irish Government, the US administration and our EU and US partners in growing investment on both sides of the Atlantic.'
